Fady Ibraham Malik - Net Worth and Insider Trading
Fady Ibraham Malik Net Worth
The estimated net worth of Fady Ibraham Malik is at least $6 Million dollars as of 2025-03-26. Fady Ibraham Malik is the EVP Research & Development of Cytokinetics Inc and owns about 140,455 shares of Cytokinetics Inc (CYTK) stock worth over $6 Million. Details can be seen in Fady Ibraham Malik's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fady Ibraham Malik has not made any transactions after 2025-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fady Ibraham Malik
Fady Ibraham Malik Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fady Ibraham Malik owns 2 companies in total, including Cytokinetics Inc (CYTK) , and Rocket Pharmaceuticals Inc (RCKT) .
Click here to see the complete history of Fady Ibraham Malik’s form 4 insider trades.
Insider Ownership Summary of Fady Ibraham Malik
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTK | Cytokinetics Inc | 2025-03-18 | SVP Research & Early Dev |
| RCKT | Rocket Pharmaceuticals Inc | 2022-03-10 | director |
Fady Ibraham Malik Latest Holdings Summary
Fady Ibraham Malik currently owns a total of 1 stock. Fady Ibraham Malik owns 140,455 shares of Cytokinetics Inc (CYTK) as of March 18, 2025, with a value of $6 Million.
Latest Holdings of Fady Ibraham Malik
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2025-03-18 | 140,455 | 43.40 | 6,095,747 |
Holding Weightings of Fady Ibraham Malik
Fady Ibraham Malik Form 4 Trading Tracker
According to the SEC Form 4 filings, Fady Ibraham Malik has made a total of 67 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 67 sells. The most-recent trade in Cytokinetics Inc is the sale of 2,000 shares on March 18, 2025, which brought Fady Ibraham Malik around $87,160.
Insider Trading History of Fady Ibraham Malik
- 1
Fady Ibraham Malik Trading Performance
Fady Ibraham Malik Ownership Network
Ownership Network List of Fady Ibraham Malik
Ownership Network Relation of Fady Ibraham Malik
Fady Ibraham Malik Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Fady Ibraham Malik is the SVP Research & Early Dev of Cytokinetics Inc. Other key executives at Cytokinetics Inc include EVP & Chief Commercial Officers Andrew Callos , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Fady Ibraham Malik made 29 insider transaction in Cytokinetics Inc (CYTK) with a net sale of 230,315. Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 326,861 shares made by Robert I Blum , a net sale of 40,000 shares made by B Lynne Parshall , and a net sale of 55,001 shares made by Andrew Callos .
In summary, during the past 3 months, insiders sold 170,428 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 170,428 shares. During the past 18 months, 709,757 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 709,757 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Fady Ibraham Malik Mailing Address
Above is the net worth, insider trading, and ownership report for Fady Ibraham Malik. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Fady Ibraham Malik's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
